Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.54 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.51 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.49 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.49 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.48 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.48 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.48 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.48 |
| ▸ | MAP4K5 | Q9Y4K4 | 1/20 | 0.48 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27430960 | 0.81 | PDGFRB (0.62) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL32667946 | 0.80 | PDGFRB (0.77) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL2772360 | 0.80 | PDGFRB (0.77) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL23555381 | 0.80 | PDGFRB (0.66) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL8370258 | 0.80 | PDGFRB (0.66) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL29375329 | 0.79 | CYP1A2 (0.56) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL28286294 | 0.79 | PDGFRB (0.54) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL15968103 | 0.79 | CYP1A2 (0.56) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL29377935 | 0.77 | NPC1 (0.61) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 | |
| SCHEMBL15344108 | 0.77 | BIRC5 (0.66) | CYP1A2PDGFRBPDGFRACYP2A6BIRC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2479160-B1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | UNIV OSAKA (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-2479160-B1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | UNIV OSAKA (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-2479160-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | Osaka University (JP) | 2012-07-25 | — | — | EP | disclosed |
| EP-2479160-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | Osaka University (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | OSAKA UNIVERSITY (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | OSAKA UNIVERSITY (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | OSAKA UNIVERSITY (JP) | 2012-07-05 | — | — | US | disclosed |
| US-7977486-B2 | Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives | OSAKA UNIVERSITY (JP) | 2011-07-12 | — | — | US | disclosed |
| WO-2011034071-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | 国立大学法人大阪大学 (JP) | 2011-03-24 | — | — | WO | disclosed |
| US-20100004454-A1 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES | OSAKA UNIVERSITY (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | TYR, AOX1, POR | CYP1A2 90/4885PDGFRB 2549/4885PDGFRA 2168/4885 |
| US-20100004454-A1 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES | APEX1, NQO1, POT1 | CYP1A2 2589/4885PDGFRB 4869/4885PDGFRA 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.